On August 22, 2023, US Bancorp DE revealed that it had increased its position in Koninklijke Philips (NYSE:PHG) by 23.7% during the first quarter, according to the company’s recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor now owns 65,989 shares of the technology company’s stock, acquiring an additional 12,659 shares during the period. As of its most recent SEC filing, US Bancorp DE’s holdings in Koninklijke Philips were valued at $1,211,000.
Koninklijke Philips is a prominent health technology company operating across North America, Greater China, and international markets. Its operations are divided into three segments: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses.
In its latest quarterly earnings report announced on July 23rd, Koninklijke Philips reported earnings per share of $0.31 for the quarter. This surpassed the consensus estimate of $0.23 by $0.08. Additionally, the company recorded a positive return on equity of 7.95% despite a negative net margin of 10.84%. Koninklijke Philips generated revenue of $4.87 billion during the quarter, exceeding analyst expectations of $4.30 billion. In comparison to the same period last year when it earned $0.15 per share earnings; this shows significant improvement for the company.
Looking ahead to the current year, analysts anticipate that Koninklijke Philips will post earnings per share of approximately 1.11.
The primary focus of Koninklijke Philips’ operations lies within its Diagnosis & Treatment Businesses segment where it provides diagnostic imaging solutions such as magnetic resonance imaging (MRI), X-ray systems, and computed tomography (CT) systems and software including detector-based spectral CT solutions for enhanced imaging analysis capabilities alongside molecular and hybrid imaging solutions for nuclear medicine.
Furthermore, the company offers echography solutions aimed at facilitating diagnosis, treatment planning, and guidance for cardiology, general imaging, obstetrics/gynecology, as well as point-of-care applications. Additionally, Koninklijke Philips caters to the need for integrated interventional systems and interventional diagnostic and therapeutic devices used in treating coronary artery and peripheral vascular disease.
The company’s comprehensive product portfolio also includes proprietary software for diagnostic and intervention purposes, as well as enterprise diagnostic informatics products and services.
In conclusion, US Bancorp DE has significantly increased its stake in Koninklijke Philips during the first quarter. With its extensive range of health technology solutions spanning across various areas of medical diagnostics and treatment, Koninklijke Philips is poised to capitalize on the growing healthcare industry worldwide.
Koninklijke Philips Witnesses Adjustments in Stakes by Institutional Investors and Hedge Funds
August 22, 2023 – Koninklijke Philips, a global technology company, has seen several institutional investors and hedge funds adjust their stakes in the company. Global Retirement Partners LLC increased its holdings in Koninklijke Philips by 47.8% in the first quarter, now owning 3,016 shares worth $63,000. Credit Suisse AG also acquired a new stake in the second quarter worth approximately $65,000.
Geneos Wealth Management Inc. raised its stake in Koninklijke Philips by an impressive 1,070.3% in the first quarter. They now own 3,745 shares valued at $69,000. Parallel Advisors LLC also saw an increase of 44% in their stake during the same period and currently owns 4,029 shares worth $74,000.
Emfo LLC showed significant interest as well, raising its stake by 132.7% in the first quarter. They now hold 6,137 shares worth $113,000. These institutional investors collectively own 6.58% of Koninklijke Philips’ stock.
As of August 22nd, shares of NYSE PHG opened at $22.47 USD. The stock’s fifty-day simple moving average is $21.24 and its two-hundred-day simple moving average is $19.40. Over the past year, Koninklijke Philips has seen a low of $11.75 and a high of $23.30.
Koninklijke Philips has a market capitalization of $20.87 billion and a price-to-earnings ratio of -9.60 with a beta of 0.
93.
The company’s current ratio stands at
1.
20 while its quick ratio is
0.
69; it also maintains a debt-to-equity ratio of
0.
59.
Several analysts have recently commented on Koninklijke Philips’ performance and outlook for the future. Citigroup, for instance, increased their price objective to €19 ($20.65) in a research note on July 7th. The Goldman Sachs Group also initiated coverage of Koninklijke Philips and assigned a “buy” rating for the company on July 12th.
StockNews.com followed suit and began covering Koninklijke Philips with a “buy” rating on August 17th. Societe Generale upgraded their previous “sell” rating to a “hold” rating in a research report released on April 25th. TheStreet also upgraded Koninklijke Philips from a “d+” rating to a “c-” rating on July 24th.
According to Bloomberg.com data, Koninklijke Philips currently holds an average rating of “Hold” among analysts, with an average target price of $17.06.
For more information and detailed analysis on Koninklijke Philips, please refer to our latest report.
Source: beststocks.com
